This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

My Cart
Shopping Cart
0 items
£0.00
View Cart

African Animal Health Market 2016

£2,250.00

Availability: In stock

SKU: 85168

Quick Overview

Livestock production; Veterinary services; Important animal diseases; Animal health products and market needs in Africa; Regulation; Trends and future outlook

Click on image to zoom

You may also be interested in ...

Product Overview

This report examines the current and potential animal health market in Africa. Sub-Saharan Africa comprises some of the poorest countries of the world with a population that is destined to increase exponentially in the coming decades with the concurrent increasing demand for food. In line with the other emerging economies, this will be accompanied by increasing demand for high quality animal protein as countries develop their wealth and middle classes emerge.

The report begins with a brief review of the global animal health industry and then discusses in detail the African market, demographics, growth drivers for African livestock, animal production systems and the need for veterinary medicines.

Production statistics for cattle, sheep and goats, pigs, poultry, companion animals and aquaculture are reviewed together with a discussion of animal types by region and country.

There is a review of veterinary legislation and the need for improved veterinary services.

The important animal diseases are covered, focussing mainly on tropical diseases but also reminding the reader that the production diseases of parasitism, respiratory and enteric disease are just as important as they are in developed countries. Diseases are discussed in the context of being vector-borne, zoonoses, transboundary etc.

There is an overview of the animal health industry in Africa including both global and regional companies. The regulatory systems for animal health products are detailed. Their status is highly variable between countries but in general there is relevant legislation but with some exceptions it is often not implemented or enforced rigorously.

To many companies Africa has to date been unattractive due to the problems of low market value and density, poor regulation, corruption, fake and counterfeit products, poor distribution networks, ineffective cold chain etc. However, others are grasping the opportunities and doing very well in finding valuable niches e.g. the poultry vaccine segment.

Format: PDF Report sent by email

PLEASE NOTE: Price now includes access for three users. For additional users, please email reports@agri.informa.com

Features & Contents

Click here for contents pages, executive summary and sample pages

More Info

Professor Andy Peters is Managing Director of Arpexas Ltd, a consultancy company providing support to the animal health sector in new product development, lead seeking and knowledge transfer, with special emphasis on vaccines.

Until November 2005 he was Head of European Vaccine R&D with Pfizer Animal Health. Between 1993 and 1998 he was Professor of Animal Health and Production at the Royal Veterinary College, London and previously Regulatory Manager with Hoechst Animal Health.

Andy is a veterinarian with PhD and DSc degrees in animal science and currently holds a special Professorship with the University of Nottingham.

He has published several previous Animal Pharm Reports – on vaccines and diagnostics - some 150 scientific papers, and two books on Vaccines for Veterinary Applications and Reproduction in Cattle respectively.

Reviews (0)

There are no reviews for this product yet. Be the first to share your experiences.